EA201100126A1 - Нафтиридиноны в качестве ингибиторов протеинкиназ - Google Patents
Нафтиридиноны в качестве ингибиторов протеинкиназInfo
- Publication number
- EA201100126A1 EA201100126A1 EA201100126A EA201100126A EA201100126A1 EA 201100126 A1 EA201100126 A1 EA 201100126A1 EA 201100126 A EA201100126 A EA 201100126A EA 201100126 A EA201100126 A EA 201100126A EA 201100126 A1 EA201100126 A1 EA 201100126A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- proteinkinaz
- nafthyridinoes
- inhibitors
- naphthyridinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Описаны соединения - производные нафтиридинона, которые ингибируют ферменты Аурора киназы, а также фармацевтические композиции, которые содержат эти соединения, и способы их синтеза. Такие соединения пригодны для лечения пролиферативных заболеваний, возникающих вследствие нерегулируемых и/или нарушенных Аурора киназ, таких как злокачественные новообразования, псориаз, вирусные и бактериальные инфекции, воспалительные и аутоиммунные заболевания.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13401808P | 2008-07-03 | 2008-07-03 | |
PCT/US2009/049035 WO2010002779A2 (en) | 2008-07-03 | 2009-06-29 | Naphthyridininones as aurora kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201100126A1 true EA201100126A1 (ru) | 2011-08-30 |
Family
ID=41466544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201100126A EA201100126A1 (ru) | 2008-07-03 | 2009-06-29 | Нафтиридиноны в качестве ингибиторов протеинкиназ |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110269758A1 (ru) |
EP (1) | EP2291376A2 (ru) |
JP (1) | JP2011526912A (ru) |
KR (1) | KR20110025856A (ru) |
CN (1) | CN102083831B (ru) |
AU (1) | AU2009267161B2 (ru) |
BR (1) | BRPI0914936A2 (ru) |
CA (1) | CA2727103A1 (ru) |
EA (1) | EA201100126A1 (ru) |
HK (1) | HK1156611A1 (ru) |
IL (1) | IL210377A (ru) |
MX (1) | MX2010013842A (ru) |
WO (1) | WO2010002779A2 (ru) |
ZA (1) | ZA201008878B (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2585461B1 (en) * | 2010-06-28 | 2020-02-26 | Merck Patent GmbH | 2,4-diaryl-substituted [1,8]naphthyridines as kinase inhibitors for use against cancer |
CN102408426B (zh) * | 2011-09-14 | 2013-07-10 | 湖南有色凯铂生物药业有限公司 | 取代的芳香脲类化合物及其作为抗癌药物的应用 |
BR112018006873A2 (pt) | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
CA3158951A1 (en) * | 2016-08-15 | 2018-02-22 | Purdue Research Foundation | 4-substituted aminoisoquinoline derivatives |
KR102055660B1 (ko) * | 2018-03-07 | 2019-12-13 | 경상대학교산학협력단 | 나프타미도-페닐아잔디일 유도체, 이를 포함하는 우라닐 이온 검출용 조성물 및 이를 이용한 우라닐 이온 검출 방법 |
KR20200100429A (ko) * | 2019-02-18 | 2020-08-26 | 한국과학기술연구원 | 단백질 키나아제 저해 활성을 갖는 신규한 피리도[3,4-d]피리미딘-8-온 유도체 및 이를 포함하는 암의 예방, 개선 또는 치료용 약학 조성물 |
EP4276100A1 (en) * | 2020-12-29 | 2023-11-15 | Txinno Bioscience Inc. | Novel naphthyridinone derivative having inhibitory activity against ectonucleotide pyrophosphatase-phosphodiesterase and use thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9127252D0 (en) * | 1991-12-23 | 1992-02-19 | Boots Co Plc | Therapeutic agents |
AR004010A1 (es) * | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
ATE300521T1 (de) * | 1996-09-25 | 2005-08-15 | Astrazeneca Ab | Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern |
GB9906566D0 (en) * | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
WO2001021596A1 (en) * | 1999-09-21 | 2001-03-29 | Astrazeneca Ab | Quinazoline derivatives and their use as pharmaceuticals |
DE60120193T2 (de) * | 2000-09-15 | 2007-03-29 | Vertex Pharmaceuticals Inc., Cambridge | Pyrazolverbindungen als protein-kinasehemmer |
ATE399766T1 (de) * | 2000-10-20 | 2008-07-15 | Eisai R&D Man Co Ltd | Stickstoff enthaltende aromatische heterozyklen |
EP1578755B1 (en) * | 2002-12-24 | 2007-08-22 | AstraZeneca AB | Phosphonooxy quinazoline derivatives and their pharmaceutical use |
PL378111A1 (pl) * | 2003-02-14 | 2006-03-06 | Smithkline Beecham Corporation | Nowe związki |
BRPI0609650A2 (pt) * | 2005-03-25 | 2010-04-20 | Tibotec Pharm Ltd | inibidores heterobicìlicos de hvc |
US20070066632A1 (en) * | 2005-03-25 | 2007-03-22 | Scios, Inc. | Fused bicyclic inhibitors of TGFbeta |
ATE541844T1 (de) * | 2005-12-21 | 2012-02-15 | Abbott Lab | Antivirale verbindungen |
-
2009
- 2009-06-29 EA EA201100126A patent/EA201100126A1/ru unknown
- 2009-06-29 EP EP09774230A patent/EP2291376A2/en not_active Withdrawn
- 2009-06-29 WO PCT/US2009/049035 patent/WO2010002779A2/en active Application Filing
- 2009-06-29 BR BRPI0914936A patent/BRPI0914936A2/pt not_active IP Right Cessation
- 2009-06-29 MX MX2010013842A patent/MX2010013842A/es not_active Application Discontinuation
- 2009-06-29 CA CA2727103A patent/CA2727103A1/en not_active Abandoned
- 2009-06-29 US US12/997,312 patent/US20110269758A1/en not_active Abandoned
- 2009-06-29 CN CN200980125942.XA patent/CN102083831B/zh not_active Expired - Fee Related
- 2009-06-29 AU AU2009267161A patent/AU2009267161B2/en not_active Ceased
- 2009-06-29 JP JP2011516760A patent/JP2011526912A/ja active Pending
- 2009-06-29 KR KR1020117002178A patent/KR20110025856A/ko not_active Application Discontinuation
-
2010
- 2010-12-09 ZA ZA2010/08878A patent/ZA201008878B/en unknown
- 2010-12-30 IL IL210377A patent/IL210377A/en not_active IP Right Cessation
-
2011
- 2011-10-12 HK HK11110851.4A patent/HK1156611A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX2010013842A (es) | 2011-01-14 |
US20110269758A1 (en) | 2011-11-03 |
WO2010002779A2 (en) | 2010-01-07 |
JP2011526912A (ja) | 2011-10-20 |
KR20110025856A (ko) | 2011-03-11 |
IL210377A0 (en) | 2011-03-31 |
AU2009267161A1 (en) | 2010-01-07 |
IL210377A (en) | 2015-03-31 |
EP2291376A2 (en) | 2011-03-09 |
CN102083831A (zh) | 2011-06-01 |
WO2010002779A3 (en) | 2011-03-03 |
CA2727103A1 (en) | 2010-01-07 |
CN102083831B (zh) | 2014-09-03 |
AU2009267161B2 (en) | 2014-11-06 |
BRPI0914936A2 (pt) | 2015-10-20 |
ZA201008878B (en) | 2012-02-29 |
HK1156611A1 (en) | 2012-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201100450A1 (ru) | Макроциклические пирамидины в качестве ингибиторов протеинкиназы | |
EA201290894A1 (ru) | Азетидиновые производные пиперидин-4-ила как ингибиторы jak1 | |
EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
EA200701930A1 (ru) | Производные пиримидина для лечения гиперпролиферативных нарушений | |
EA201400111A1 (ru) | Ингибиторы mek и способы их применения | |
EA201170531A1 (ru) | Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака | |
EA201491356A1 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
EA201291143A1 (ru) | Пиразолилхиназолиновые ингибиторы киназы | |
EA201070247A1 (ru) | Ингибиторы протеасом | |
ATE362932T1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
EA201171454A1 (ru) | N-(ГЕТЕРО)АРИЛПИРРОЛИДИНОВЫЕ ПРОИЗВОДНЫЕ ПИРАЗОЛ-4-ИЛПИРРОЛО[2,3-d]ПИРИМИДИНОВ И ПИРРОЛ-3-ИЛПИРРОЛО[2,3-d]ПИРИМИДИНОВ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ | |
EA200970738A1 (ru) | Ингибиторы активности akt | |
EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
EA201290147A1 (ru) | Пирроло[2,3-d]пиримидиновые соединения | |
EA201000149A1 (ru) | Производные 1-фенил-2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстераз | |
EA200900819A1 (ru) | Хиназолины для ингибирования pdk1 | |
ATE532789T1 (de) | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren | |
ECSP088906A (es) | PIRAZOLO 1,5-a PIRIMIDINAS | |
MX2012002542A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina. | |
EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
ATE493418T1 (de) | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren | |
EA201100126A1 (ru) | Нафтиридиноны в качестве ингибиторов протеинкиназ | |
EA201270535A1 (ru) | Пуриновые производные, применимые в качестве ингибиторов hsp90 | |
EA201071224A1 (ru) | Ингибиторы limk2, композиции, содержащие их, и способы их применения | |
EA201170680A1 (ru) | Ингибиторы акт и p70 s6-киназы |